NO20014987D0 - Substituerte azoler - Google Patents

Substituerte azoler

Info

Publication number: NO20014987D0
Authority: NO; Norway
Prior art keywords: substituted azoles; azoles; substituted
Prior art date: 1999-04-14

Application number

NO20014987A

Other languages

English (en)

Other versions

NO20014987L (no

Inventor

Laszlo Revesz

Achim Schlapbach

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-14

Filing date

2001-10-12

Publication date

2001-10-12

1999-04-14 Priority claimed from GBGB9908532.6A external-priority patent/GB9908532D0/en

1999-04-14 Priority claimed from GBGB9908531.8A external-priority patent/GB9908531D0/en

2001-10-12 Application filed by Novartis Ag filed Critical Novartis Ag

2001-10-12 Publication of NO20014987D0 publication Critical patent/NO20014987D0/no

2001-12-14 Publication of NO20014987L publication Critical patent/NO20014987L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Hematology (AREA)
Neurology (AREA)
Oncology (AREA)
Transplantation (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Communicable Diseases (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Gastroenterology & Hepatology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20014987A 1999-04-14 2001-10-12 Substituerte azoler NO20014987L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9908532.6A GB9908532D0 (en)	1999-04-14	1999-04-14	Organic compounds
GBGB9908531.8A GB9908531D0 (en)	1999-04-14	1999-04-14	Organic compounds
PCT/EP2000/003290 WO2000063204A2 (en)	1999-04-14	2000-04-12	Substituted azoles

Publications (2)

Publication Number	Publication Date
NO20014987D0 true NO20014987D0 (no)	2001-10-12
NO20014987L NO20014987L (no)	2001-12-14

Family

ID=26315413

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20014987A NO20014987L (no)	1999-04-14	2001-10-12	Substituerte azoler

Country Status (25)

Country	Link
US (1)	US6579874B2 (no)
EP (1)	EP1224180B1 (no)
JP (1)	JP2003503311A (no)
KR (1)	KR20010108504A (no)
CN (1)	CN1378544A (no)
AR (1)	AR023465A1 (no)
AT (1)	ATE244236T1 (no)
AU (1)	AU4295300A (no)
BR (1)	BR0010598A (no)
CA (1)	CA2370417A1 (no)
CO (1)	CO5170501A1 (no)
CZ (1)	CZ20013696A3 (no)
DE (1)	DE60003709T2 (no)
DK (1)	DK1224180T3 (no)
ES (1)	ES2202114T3 (no)
HU (1)	HUP0302747A2 (no)
IL (1)	IL145836A0 (no)
MX (1)	MXPA01010434A (no)
NO (1)	NO20014987L (no)
PE (1)	PE20010031A1 (no)
PL (1)	PL364789A1 (no)
PT (1)	PT1224180E (no)
SK (1)	SK14562001A3 (no)
TR (1)	TR200102967T2 (no)
WO (1)	WO2000063204A2 (no)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU770600B2 (en)	1999-10-07	2004-02-26	Amgen, Inc.	Triazine kinase inhibitors
AU7922900A (en) *	1999-10-27	2001-05-08	Novartis Ag	Thiazole and imidazo (4,5-b) pyridine compounds and their pharmaceutical use
US20030004174A9 (en) *	2000-02-17	2003-01-02	Armistead David M.	Kinase inhibitors
CN1307173C (zh)	2000-12-21	2007-03-28	葛兰素集团有限公司	作为血管生成调节剂的嘧啶胺
CA2436739A1 (en) *	2000-12-26	2002-07-04	Takeda Chemical Industries, Ltd.	Combination agent
CA2437248A1 (en) *	2001-02-02	2002-08-15	Takeda Chemical Industries, Ltd.	Jnk inhibitor
AP2002002460A0 (en)	2001-03-09	2002-06-30	Pfizer Prod Inc	Novel benzimidazole anti-inflammatory compounds.
EP1370559B1 (en)	2001-03-09	2006-04-19	Pfizer Products Inc.	Triazolopyridines as anti-inflammatory agents
EP1247810B1 (en)	2001-04-04	2005-09-07	Pfizer Products Inc.	Novel benzotriazoles anti-inflammatory compounds
EP1402900A1 (en) *	2001-06-11	2004-03-31	Takeda Chemical Industries, Ltd.	Medicinal compositions
PL368441A1 (en)	2001-09-21	2005-03-21	Solvay Pharmaceuticals B.V.	Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
TWI231757B (en) *	2001-09-21	2005-05-01	Solvay Pharm Bv	1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
US7109216B2 (en)	2001-09-21	2006-09-19	Solvay Pharmaceuticals B.V.	1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
US7473695B2 (en) *	2001-10-22	2009-01-06	Mitsubishi Tanabe Pharma Corporation	4-imidazolin-2-one compounds
WO2003053922A2 (en) *	2001-12-19	2003-07-03	Merck & Co., Inc.	Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
AR039241A1 (es) *	2002-04-04	2005-02-16	Biogen Inc	Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
ES2278170T3 (es)	2002-07-09	2007-08-01	BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG	Composiciones farmaceuticas de anticolinergicos e inhibidores de la quinasa p38 en el tratamiento de enfermedades respiratorias.
IL166510A0 (en)	2002-08-09	2006-01-15	Nps Pharma Inc	1,2,4"oxadiazole as modulators of metabotropic glutamate receptor-5
AR041508A1 (es) *	2002-08-09	2005-05-18	Astra Ab	Compuestos con actividad en los receptores de glutamato metabotropicos
US7074809B2 (en)	2002-08-09	2006-07-11	Astrazeneca Ab	Compounds
MXPA05002123A (es) *	2002-08-30	2005-06-06	Pfizer Prod Inc	Nuevos procedimientos e intermedios para preparar triazolo-piridinas.
US6949652B2 (en)	2002-08-30	2005-09-27	Pfizer, Inc.	Crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-A]pyridine
US7037923B2 (en)	2002-08-30	2006-05-02	Pfizer, Inc.	Alkyl-[4-(trifluorophenyl)-oxazol-5-yl]-triazolo-pyridines
US7005523B2 (en)	2002-08-30	2006-02-28	Pfizer Inc.	Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines
PA8579601A1 (es) *	2002-08-30	2004-05-07	Pfizer Prod Inc	Compuestos antiinflamatorios de di y trifloruro-triazolo-piridinas
US7012143B2 (en)	2002-08-30	2006-03-14	Dombroski Mark A	Cycloalkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines
UA80295C2 (en) *	2002-09-06	2007-09-10	Biogen Inc	Pyrazolopyridines and using the same
AU2003300076C1 (en)	2002-12-30	2010-03-04	Angiotech International Ag	Drug delivery from rapid gelling polymer composition
RU2332412C2 (ru)	2003-02-07	2008-08-27	Дайити Фармасьютикал Ко., Лтд.	Производные пиразола
EP1601672B1 (en)	2003-02-14	2006-07-26	Pfizer Products Inc.	Triazolo-pyridines as anti-inflammatory compounds
MY143245A (en) *	2004-04-28	2011-04-15	Mitsubishi Tanabe Pharma Corp	4- 2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases
US7858800B2 (en)	2004-06-30	2010-12-28	Banyu Pharmaceutical Co., Ltd.	Biaryl derivatives
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
WO2007092911A2 (en) *	2006-02-08	2007-08-16	The General Hospital Corporation	Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy
ES2301380B1 (es)	2006-08-09	2009-06-08	Laboratorios Almirall S.A.	Nuevos derivados de 1,7-naftiridina.
ES2320955B1 (es)	2007-03-02	2010-03-16	Laboratorios Almirall S.A.	Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
ES2329639B1 (es)	2007-04-26	2010-09-23	Laboratorios Almirall S.A.	Nuevos derivados de 4,8-difenilpoliazanaftaleno.
EP2142521A1 (en)	2007-04-30	2010-01-13	Abbott Laboratories	Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
JP5581219B2 (ja)	2008-01-25	2014-08-27	ミレニアムファーマシューティカルズ，インコーポレイテッド	チオフェンおよびホスファチジルイノシトール３−キナーゼ（ｐｉ３ｋ）阻害薬としてのその使用
EP2108641A1 (en)	2008-04-11	2009-10-14	Laboratorios Almirall, S.A.	New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
EP2113503A1 (en)	2008-04-28	2009-11-04	Laboratorios Almirall, S.A.	New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
US9090601B2 (en)	2009-01-30	2015-07-28	Millennium Pharmaceuticals, Inc.	Thiazole derivatives
WO2010090716A1 (en)	2009-01-30	2010-08-12	Millennium Pharmaceuticals, Inc.	Heteroaryls and their use as pi3k inhibitors
US8796314B2 (en)	2009-01-30	2014-08-05	Millennium Pharmaceuticals, Inc.	Heteroaryls and uses thereof
CA2760911A1 (en) *	2009-05-19	2010-11-25	George E. Davis	Compounds and methods for controlling fungi
EP2322176A1 (en)	2009-11-11	2011-05-18	Almirall, S.A.	New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
JP2013533318A (ja)	2010-08-11	2013-08-22	ミレニアムファーマシューティカルズ，インコーポレイテッド	ヘテロアリールおよびその使用
PH12013500274A1 (en)	2010-08-11	2013-03-04	Millennium Pharm Inc	Heteroaryls and uses thereof
WO2012021611A1 (en)	2010-08-11	2012-02-16	Millennium Pharmaceuticals, Inc.	Heteroaryls and uses thereof
WO2012051410A2 (en)	2010-10-13	2012-04-19	Millennium Pharmaceuticals, Inc.	Heteroaryls and uses thereof
AR086113A1 (es)	2011-04-30	2013-11-20	Abbott Lab	Isoxazolinas como agentes terapeuticos
US20190060286A1 (en)	2016-02-29	2019-02-28	University Of Florida Research Foundation, Incorpo	Chemotherapeutic Methods
JPWO2018159650A1 (ja) *	2017-02-28	2019-12-19	東レ株式会社	グアニジン誘導体及びその医薬用途
WO2021138391A1 (en)	2019-12-30	2021-07-08	Tyra Biosciences, Inc.	Indazole compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1306377A3 (en) *	1993-11-08	2003-05-07	Smithkline Beecham Corporation	Pyridyl-oxazoles and their use as cytokines inhibitors
IL118544A (en) *	1995-06-07	2001-08-08	Smithkline Beecham Corp	History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
US5739143A (en) *	1995-06-07	1998-04-14	Smithkline Beecham Corporation	Imidazole compounds and compositions
CA2228136A1 (en) *	1995-08-10	1997-02-20	Merck & Co., Inc.	2-substituted aryl pyrroles, compositions containing such compounds and methods of use
US6492516B1 (en) *	1999-05-14	2002-12-10	Merck & Co., Inc.	Compounds having cytokine inhibitory activity

2000
- 2000-04-11 CO CO00026470A patent/CO5170501A1/es not_active Application Discontinuation
- 2000-04-12 IL IL14583600A patent/IL145836A0/xx unknown
- 2000-04-12 AR ARP000101686A patent/AR023465A1/es unknown
- 2000-04-12 AT AT00922630T patent/ATE244236T1/de not_active IP Right Cessation
- 2000-04-12 PE PE2000000337A patent/PE20010031A1/es not_active Application Discontinuation
- 2000-04-12 MX MXPA01010434A patent/MXPA01010434A/es unknown
- 2000-04-12 DK DK00922630T patent/DK1224180T3/da active
- 2000-04-12 AU AU42953/00A patent/AU4295300A/en not_active Abandoned
- 2000-04-12 CN CN00807552A patent/CN1378544A/zh active Pending
- 2000-04-12 TR TR2001/02967T patent/TR200102967T2/xx unknown
- 2000-04-12 SK SK1456-2001A patent/SK14562001A3/sk unknown
- 2000-04-12 CZ CZ20013696A patent/CZ20013696A3/cs unknown
- 2000-04-12 ES ES00922630T patent/ES2202114T3/es not_active Expired - Lifetime
- 2000-04-12 HU HU0302747A patent/HUP0302747A2/hu unknown
- 2000-04-12 PT PT00922630T patent/PT1224180E/pt unknown
- 2000-04-12 WO PCT/EP2000/003290 patent/WO2000063204A2/en not_active Ceased
- 2000-04-12 CA CA002370417A patent/CA2370417A1/en not_active Abandoned
- 2000-04-12 EP EP00922630A patent/EP1224180B1/en not_active Expired - Lifetime
- 2000-04-12 KR KR1020017013086A patent/KR20010108504A/ko not_active Withdrawn
- 2000-04-12 BR BR0010598-8A patent/BR0010598A/pt not_active IP Right Cessation
- 2000-04-12 DE DE60003709T patent/DE60003709T2/de not_active Expired - Fee Related
- 2000-04-12 JP JP2000612294A patent/JP2003503311A/ja active Pending
- 2000-04-12 PL PL00364789A patent/PL364789A1/xx not_active Application Discontinuation
2001
- 2001-10-12 US US09/975,913 patent/US6579874B2/en not_active Expired - Fee Related
- 2001-10-12 NO NO20014987A patent/NO20014987L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN1378544A (zh)	2002-11-06
PL364789A1 (en)	2004-12-13
MXPA01010434A (es)	2002-03-27
NO20014987L (no)	2001-12-14
PT1224180E (pt)	2003-11-28
CA2370417A1 (en)	2000-10-26
PE20010031A1 (es)	2001-02-23
EP1224180A2 (en)	2002-07-24
KR20010108504A (ko)	2001-12-07
DK1224180T3 (da)	2003-10-20
WO2000063204A3 (en)	2002-05-23
CO5170501A1 (es)	2002-06-27
ATE244236T1 (de)	2003-07-15
SK14562001A3 (sk)	2002-03-05
JP2003503311A (ja)	2003-01-28
BR0010598A (pt)	2002-02-05
HUP0302747A2 (hu)	2003-12-29
ES2202114T3 (es)	2004-04-01
IL145836A0 (en)	2002-07-25
US6579874B2 (en)	2003-06-17
US20020049220A1 (en)	2002-04-25
AU4295300A (en)	2000-11-02
WO2000063204A2 (en)	2000-10-26
TR200102967T2 (tr)	2002-01-21
EP1224180B1 (en)	2003-07-02
AR023465A1 (es)	2002-09-04
DE60003709D1 (de)	2003-08-07
DE60003709T2 (de)	2004-12-23
CZ20013696A3 (cs)	2002-02-13

Publication	Publication Date	Title
DK1224180T3 (da)	2003-10-20	Substituerede azoler
NO20016115D0 (no)	2001-12-14	Substituerte heterocykelkondenserte gamma-karboliner
EE200100502A (et)	2002-12-16	Ühendid
DE122007000064I1 (de)	2008-01-03	Erythropoietinkonjugate
EE200300049A (et)	2004-10-15	Imidasooli derivaadid
DE10084676T1 (de)	2003-04-30	Einmallanzettvorrichtung
ATA51899A (de)	2002-04-15	Handstempel
ATE291575T1 (de)	2005-04-15	N-carbamoyloxyalkyl-substituierte azolium- verbindungen
ATE360620T1 (de)	2007-05-15	Imidazolderivate
ATE357433T1 (de)	2007-04-15	4-pyrimidinyl-n-acyl-l-phenylanine
DK1070708T3 (da)	2004-05-10	Triazolderivater
ATE297895T1 (de)	2005-07-15	4-pyridinyl-n-acyl-l-phenylalanine
NO20013769L (no)	2001-09-26	Kalsilytiske forbindelser
NO20020466L (no)	2002-03-20	Kalsilytiske forbindelser
DE10085008T1 (de)	2002-10-10	Oberflächenbehandlungsdüse
NO20014262D0 (no)	2001-09-03	Tiazoloindolinon-forbindelser
NO20022927L (no)	2002-06-18	Substituerte pyrrazoler
ATE440824T1 (de)	2009-09-15	Nitro-sulfobenzamide
ATE269311T1 (de)	2004-07-15	Benzoylpyridazine
ATA121799A (de)	2002-03-15	Ausbeulgerät
ATE251154T1 (de)	2003-10-15	Substituierte phenyluracile
ID29984A (id)	2001-10-25	Senyawa-senyawa bis-stirilbifenil
DE50003283D1 (de)	2003-09-18	Exzenterspannzwinge
ATA107599A (de)	2002-06-15	Heizwasserbereiter
DE10085167T1 (de)	2002-11-07	Gangumschalteinrichtung

Legal Events

Date	Code	Title	Description
2004-12-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application